Dicot Pharma AB (STO:DICOT)

Dicot Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	92.8	113.42	47.34	9.38	30.33	20.33
Cash & Short-Term Investments	92.8	113.42	47.34	9.38	30.33	20.33
Cash Growth	189.77%	139.58%	404.88%	-69.08%	49.20%	66.30%
Other Receivables	5.2	3.47	2.3	1.14	1.01	0.9
Receivables	5.2	3.47	2.3	1.14	1.01	0.9
Inventory	4.5	5.38	3.4	1.49	-	-
Prepaid Expenses	-	1.35	0.5	0.34	0.4	0.34
Other Current Assets	-	-	-0	-	-	-
Total Current Assets	102.5	123.62	53.54	12.35	31.74	21.57
Property, Plant & Equipment	-	-	0.01	0.02	0.03	0.04
Total Assets	102.5	123.62	53.56	12.37	31.77	21.61
Accounts Payable	-	6.84	4.54	3.42	2.58	1.49
Accrued Expenses	-	4.05	3.98	1.19	0.66	0.37
Other Current Liabilities	14.1	1.07	0.64	2.41	0.19	0.09
Total Current Liabilities	14.1	11.96	9.16	7.01	3.42	1.95
Total Liabilities	14.1	11.96	9.16	7.01	3.42	1.95
Common Stock	12.5	12.45	5.72	17.14	12.86	5.46
Additional Paid-In Capital	-	299	180.76	86.15	81.67	53.2
Retained Earnings	-	-199.79	-142.09	-97.93	-66.18	-39
Comprehensive Income & Other	75.9	-	-	-	-	-
Shareholders' Equity	88.4	111.67	44.39	5.36	28.35	19.66
Total Liabilities & Equity	102.5	123.62	53.56	12.37	31.77	21.61
Net Cash (Debt)	92.8	113.42	47.34	9.38	30.33	20.33
Net Cash Growth	189.77%	139.58%	404.88%	-69.08%	49.20%	66.30%
Net Cash Per Share	0.07	0.10	0.09	0.08	0.47	0.71
Filing Date Shares Outstanding	1,779	1,779	817.56	137.1	102.9	43.67
Total Common Shares Outstanding	1,779	1,779	817.56	137.1	102.9	43.67
Working Capital	88.4	111.67	44.38	5.34	28.32	19.62
Book Value Per Share	0.05	0.06	0.05	0.04	0.28	0.45
Tangible Book Value	88.4	111.67	44.39	5.36	28.35	19.66
Tangible Book Value Per Share	0.05	0.06	0.05	0.04	0.28	0.45
Machinery	-	-	0.04	0.04	0.04	0.04

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.